1,099 followers
RT @HarmonyTurk: “A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer” is…
RT @HarmonyTurk: “A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer” is…
"A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer" Rodríguez Y [..] Abdulkadir. Cancer Res 2022-04-11. https://t.co/WmlBBOWJ2c
RT @Mike_C_Burns: Congrats @rz_yara @SarkiAbdulkadi1 and the whole team! PRRX2 regulates enzalutamide resistance & a path to overcoming it!…